This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Brown, R. T. Articles by Sexson, S. B. Search for Related Content PubMed PubMed Citation Articles by Brown, R. T. Articles by Sexson, S. B. Social Bookmarking                         What's this?

A Controlled Trial of Methylphenidate in Black Adolescents

Attentional, Behavioral, and Physiological Effects

Division of Child and Adolescent Psychiatry, Emory University School of Medicine, Atlanta, Georgia

Sandra B. Sexson, MD

Division of Child and Adolescent Psychiatry, Emory University School of Medicine, Atlanta, Georgia

The short-term effects of methylphenidate were examined on behavioral, laboratory, academic, and physiological measures in 11 black male adolescents diagnosed as having attention deficit disorder (ADD). In a double-blind, crossover design with randomized order, the subjects received placebo and each of three methylphenidate doses (0.15 mg/kg, 0.30 mg/kg, and 0.50 mg/kg) for a period of 2 weeks per medication dosage. Significant drug effects were found for the majority of measures. In general, the higher doses resulted in the most beneficial response in behavioral, academic, and laboratory measures of attention and impulsivity. However, a significant linear increase occurred in diastolic blood pressure. The results suggest that methylphenidate is an effective adjunct to the treatment of ADD in adolescents.

Clinical Pediatrics, Vol. 27, No. 2, 74-81 (1988)
DOI: 10.1177/000992288802700204


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				H. Hervey-Jumper, K. Douyon, T. Falcone, and K. N. Franco Identifying, Evaluating, Diagnosing, and Treating ADHD in Minority Youth J Atten Disord, March 1, 2008; 11(5): 522 - 528. [Abstract] [PDF]

				T. E. Wilens, J. B. Prince, T. J. Spencer, and J. Biederman Stimulants and Sudden Death: What Is a Physician to Do? Pediatrics, September 1, 2006; 118(3): 1215 - 1219. [Abstract] [Full Text] [PDF]

				L. A. Hazel-Fernandez, R. Klorman, J. M. Wallace, and S. Cook Methylphenidate improves aspects of executive function in african american children with ADHD. J Atten Disord, May 1, 2006; 9(4): 582 - 589. [Abstract] [PDF]

				V.J. Samuel, S. Curtis, A. Thornell, P. George, A. Taylor, D. R. Brome, J. Biederman, and S.V. Faraone The unexplored void of ADHD and African-American research: A review of the literature J Atten Disord, January 1, 1997; 1(4): 197 - 207. [Abstract]

				L. H. McCormick, G. T. Rizzuto, and H. B. Knuckles A Pilot Study of Buspirone in Attention-Deficit Hyperactivity Disorder Arch Fam Med, January 1, 1994; 3(1): 68 - 70. [Abstract] [PDF]

				L. K. Laird and J. J. Saklad Attention-Deficit Hyperactivity Disorder Journal of Pharmacy Practice, January 1, 1990; 3(4): 241 - 251. [Abstract] [PDF]